Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients
Status: | Recruiting |
---|---|
Conditions: | Asthma |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 5 - Any |
Updated: | 12/20/2018 |
Start Date: | September 2016 |
End Date: | January 2020 |
Contact: | Marina Reznik, MD, MS |
Email: | mreznik@montefiore.org |
Phone: | 7187412494 |
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma
This study will evaluate the role of using electronic sensors for asthma inhaler devices in
monitoring medication adherence and asthma control
monitoring medication adherence and asthma control
This study will assess the feasibility of using electronic sensors for asthma inhalers in a
population of urban minority adults and children with moderate-severe asthma in the Bronx.
Investigators will also assess differences in asthma outcomes (specifically asthma control as
a primary outcome measure) and treatment adherence in a group of participants with
moderate-severe asthma who use inhalers with electronic sensors and real-time remote outreach
worker monitoring/feedback compared to a group of participants who use inhalers with
electronic sensors but without real-time monitoring/feedback.
population of urban minority adults and children with moderate-severe asthma in the Bronx.
Investigators will also assess differences in asthma outcomes (specifically asthma control as
a primary outcome measure) and treatment adherence in a group of participants with
moderate-severe asthma who use inhalers with electronic sensors and real-time remote outreach
worker monitoring/feedback compared to a group of participants who use inhalers with
electronic sensors but without real-time monitoring/feedback.
Inclusion Criteria:
- Adults (>18 years) and children (5-11 years old) with a clinical history (i.e.
physician-diagnosed) of asthma
- Moderate to severe asthmatics with ≥1 asthma-related ED visits or hospitalizations in
the past year
- Use of daily controller inhaler medications
- Adult non-smokers, or lifetime use <5 pack years with no smoking in last 1 yr
- Smartphone required
- English or Spanish speaking
Exclusion Criteria:
- No smartphone
- Use of oral corticosteroids in prior 4 weeks
- Pregnancy
- Psychiatric conditions
We found this trial at
1
site
3550 Jerome Avenue
Bronx, New York 10467
Bronx, New York 10467
(718) 920-4321
Phone: 718-741-2494
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials